AKT survival signaling as a determinant of ovarian cancer chemoresistance and clinical outcome

Authors :: I. Ramirez
F. Abbasi
Bernadette M. Boac
Yuning Xiong
Douglas C. Marchion
C. McClung
Stephen H. Bush
P.L. Judson Lancaster
J.M. Lancaster
E. Al Sawah
Source :: Gynecologic Oncology. 137:175
Publication Year :: 2015
Publisher :: Elsevier BV, 2015.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Obstetrics and Gynecology
medicine.disease
Outcome (game theory)
Internal medicine
medicine
Survival signaling
business
Ovarian cancer
Protein kinase B
A determinant

Tools